Home Compare GILD vs GSK.L
Stock Comparison · Industry comparison · Drug Manufacturers - General

Gilead Sciences vs GSK: Which Stock Looks Stronger in 2026?

Gilead Sciences leads structurally, with growth as the clearest single gap between the two profiles. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (GILD: Nasdaq 100, GSK.L: STOXX 600).

Updated 2026-05-17

The comparison is mainly decided in growth, with the rest of the profile carrying less weight.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. GILD and GSK.L share the same industry classification.

For a similarity-based comparison, see how Gilead Sciences and GSK each position within their functional peer groups in AssetNext.

Peer-Relative Score
GILD
Gilead Sciences, Inc.
74
Peer-Score
Signal qualitylow
Peer basis: Nasdaq 100
vs
GSK.L
GSK plc
67
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: GILD vs GSK.L Profitability 74 68 Stability 75 76 Valuation 85 84 Growth 56 30 GILD GSK.L
Gap Ranking
#1 Growth +26
#2 Profitability +6
#3 Valuation +1
#4 Stability +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GILD and GSK.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GILDGSK.L Relative valuation Structural strength

Gilead Sciences, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Gilead Sciences, Inc. is positioned higher in the group, while GSK plc is closer to the middle.
Growth — Dominant Gap
GILD
56
GSK.L
30
Gap+26in favour of GILD

Earnings growth is one contributing factor within the growth lead.

What else supports the lead

Gilead Sciences, Inc. also shows lower market-fundamental divergence, which makes the lead look less detached from the underlying business picture.

What this means for the comparison

Growth answers the question more clearly than the overall score separation does.

Explore full peer positioning in AssetNext

Break down the GILD vs GSK.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-driven comparisons

Explore how GILD and GSK.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.